Page last updated: 2024-10-29

ketanserin and Brain Hemorrhage, Cerebral

ketanserin has been researched along with Brain Hemorrhage, Cerebral in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research Excerpts

ExcerptRelevanceReference
"The response of arterial BP and intracranial pressure to an intravenous injection of the serotonin antagonist, ketanserin, was recorded in ten patients with hypertension following intracerebral haemorrhage."9.07Effect of intravenous ketanserin on arterial and intracranial pressures in patients with systemic hypertension following intracerebral haemorrhage. ( Kay, R; Nicholls, MG; Poon, WS, 1993)
"The response of arterial BP and intracranial pressure to an intravenous injection of the serotonin antagonist, ketanserin, was recorded in ten patients with hypertension following intracerebral haemorrhage."5.07Effect of intravenous ketanserin on arterial and intracranial pressures in patients with systemic hypertension following intracerebral haemorrhage. ( Kay, R; Nicholls, MG; Poon, WS, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kay, R1
Poon, WS1
Nicholls, MG1

Trials

1 trial available for ketanserin and Brain Hemorrhage, Cerebral

ArticleYear
Effect of intravenous ketanserin on arterial and intracranial pressures in patients with systemic hypertension following intracerebral haemorrhage.
    Journal of human hypertension, 1993, Volume: 7, Issue:4

    Topics: Blood Pressure; Cerebral Hemorrhage; Female; Humans; Hypertension; Injections, Intravenous; Intracra

1993